Open AccessSAT-300 EFFECTS OF DAPAGLIFLOZIN AND DAPAGLIFLOZIN PLUS SAXAGLIPTIN ON HbA1c AND ALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE: PHASE II/III DELIGHT STUDY
Author(s) -
Carol A. Pollock,
David C. Wheeler,
Peter Rossing,
C. David Sjöström,
Bergur V. Stefánsson,
Daniel Reyner,
Anna Maria Langkilde,
Hiddo J.L. Heerspink
Publication year - 2019
Publication title -
kidney international reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.225
H-Index - 22
ISSN - 2468-0249
DOI - 10.1016/j.ekir.2019.05.340
Subject(s) - dapagliflozin , saxagliptin , albuminuria , medicine , type 2 diabetes , glycemic , dipeptidyl peptidase 4 , diabetes mellitus , kidney disease , urology , renal function , endocrinology , sitagliptin
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom